Spots Global Cancer Trial Database for Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery

Official Title: Bilateral Superficial Cervical Plexus Block Combined With Intravenous Sedation Versus General Anesthesia in Selected Patients for Thyroid/Parathyroid Surgery ; a Prospective Randomized Control Trial

Study ID: NCT04051099

Conditions

Benign Tumor of Thyroid

Hyperparathyroidism

Interventions

Bilateral superficial cervical plexus block with 0.25% bupivacaine 8 ml each (total 16 ml)

Dexmedetomidine plus propofol infusion

Local infiltraion analgesia

General anesthesia with endotracheal tube

Study Description

Brief Summary: To compare efficacy and safety between bilateral superficial cervical plexus block combined with intravenous sedation (RA group) and general anesthesia (GA group) for thyroid and parathyroid operations. This study evaluates postoperative numerical pain score and systemic opioid requirement within 24 hours.

Detailed Description: According to literature review, there is limit information about efficacy and safety of thyroid and parathyroid operations under bilateral superficial cervical plexus block combined with intravenous sedation without general anesthesia. General anesthesia is commonly used for neck operations because it is easy to perform. However in high cardiovascular or pulmonary risk patients such as end stage renal disease (ESRD) patients, regional anesthesia such as superficial cervical plexus block combined with intravenous sedation have become an alternative technique for neck operations. This study evaluate whether regional anesthesia (RA) technique can be the alternative technique for thyroid/parathyroid surgery compare to conventional technique (GA).